Cullinan Therapeutics, Inc. CGEM Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s change in AP?
- Cullinan Therapeutics, Inc. (CGEM) reported change in AP of $1.67M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s change in AP changed year-over-year?
- Cullinan Therapeutics, Inc.'s change in AP decreased by 3.1% year-over-year, from $1.72M to $1.67M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.